Publications by authors named "Michael Warwick Conway"

Rationale: Validating preclinical biomarkers that predict treatment efficacy remains a critical imperative for neuropsychiatric drug discovery. With the establishment of novel in vivo imaging methods, it has become possible to think how such translational proof-of-concept studies may look.

Objectives: The aim of this study was to use in vivo oxygen (O2) amperometry to simultaneously assess the regional and event/task-related O2 changes induced by ketamine challenge in rats, and to determine whether both of these signals are equivalently affected by the mGlu2/3 receptor agonist LY379268.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Michael Warwick Conway"

  • - Michael Warwick Conway's research focuses on neuropsychiatric drug discovery, particularly the validation of preclinical biomarkers that predict treatment efficacy through innovative in vivo imaging methods.
  • - One key study analyzed the effects of the mGlu2/3 receptor agonist LY379268 on oxygen signal changes induced by ketamine in rats, exploring the relationship between regional and event-related oxygen dynamics.
  • - The findings contribute to a better understanding of how specific agonist treatments can modulate biological responses in the context of psychiatric conditions, highlighting the potential for using these biomarkers in translational research.